HQL - Tekla Life Sciences Investors

Industry: Closed-End Fund - Equity Sector: Financial Exchange: NYSE

HQL - Tekla Life Sciences Investors

Industry: Closed-End Fund - Equity Sector: Financial Exchange: NYSE
#2375()/7615

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 1.49%
PRICE $19.76
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Request Prediction
0.00%
Predict

Tekla Life Sciences Investors Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Buy candidate since 2018-09-18
Shorts 0.44% ( 2013-01-15 )
Cash n/a
Loans n/a
Beta 1.53
ROA 11.15

Tekla Life Sciences Investors gained 1.49% in the last trading day, rising from $19.47 to $19.76 The price has fallen in 7 of the last 10 days and is down by -3.09% for this period. Volume fell in the last day by -8 083 shares, and in total, 46 629 shares bought and sold for approximately $921 389.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

Tekla Life Sciences Investors lies in the middle of a weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.46% during the next 3 months and, with 90% probability hold a price between $20.04 and $21.61 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Tekla Life Sciences Investors holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $19.91. On a fall, the stock will find some support from the short-term average at $19.63. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Tekla Life Sciences Investors finds support from accumulated volume at $19.75.

Support: $19.75 Price: $19.76 Resistance: $19.81

Risk

In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Our recommended stoploss: $18.73 (-5.21%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Buy Candidate

Click for Top 5 Buy Candidates
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL